Emerging Infectious Diseases (Apr 2021)

Blastomycosis Surveillance in 5 States, United States, 1987–2018

  • Kaitlin Benedict,
  • Suzanne Gibbons-Burgener,
  • Anna Kocharian,
  • Malia Ireland,
  • Laura Rothfeldt,
  • Natalie Christophe,
  • Kimberly Signs,
  • Brendan R. Jackson

DOI
https://doi.org/10.3201/eid2704.204078
Journal volume & issue
Vol. 27, no. 4
pp. 999 – 1006

Abstract

Read online

Blastomycosis is caused by inhalation of Blastomyces spp. fungi. Limited data are available on the incidence and geographic range of blastomycosis in the United States. To better characterize its epidemiologic features, we analyzed combined surveillance data from the 5 states in which blastomycosis is reportable: Arkansas, Louisiana, Michigan, Minnesota, and Wisconsin. Surveillance identified 4,441 cases during 1987–2018, a mean of 192 cases per year. The mean annual incidence was 20 cases/100,000 population in some northern counties of Wisconsin. Median patient age was 46 years, 2,892 (65%) patients were male, 1,662 (57%) were hospitalized, and 278 (8%) died. The median time from symptom onset to diagnosis was 33 days. The severity of illness and diagnostic delays suggest that surveillance underestimates the true number of cases. More in-depth surveillance in additional states could elucidate blastomycosis incidence and inform efforts to increase awareness.

Keywords